Xenon Pharmaceuticals Inc.
XENE | NASDAQ
$37.62
+$0.21 (+0.56%)
At close: Nov 2, 2026, 4:00 PM ET
$38.01
+$0.60 (+1.60%)
Pre-market:
Nov 2, 2026, 9:25 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -409.2M | -383.17M | -345.91M | -306.33M | -278.23M | -251.45M | -234.33M | -213.39M | -199.06M | -188.6M | -182.39M | -175.05M | -163.73M | -147.43M | -125.37M | -113.54M | -91.84M | -82.79M | -78.88M | -65.64M | -59.05M | -37.12M |
Depreciation & Amortization | 2.4M | 2.47M | 2.54M | 2.57M | 2.62M | 2.65M | 2.58M | 2.8M | 3.83M | 3.77M | 3.54M | 3.21M | 1.83M | 1.6M | 1.62M | 1.38M | 1.23M | 1.09M | 906K | 838K | 800K | 736K |
Stock-Based Compensation | 61.45M | 58.43M | 53.71M | 53.19M | 52.49M | 53.49M | 50.72M | 46.3M | 42.04M | 35.78M | 32.37M | 29M | 26M | 22.76M | 20.38M | 17.27M | 14.17M | 11.67M | 10.02M | 8.92M | 6.28M | 3.58M |
Other Working Capital | 10.18M | 3.54M | 4.09M | 378K | -4.54M | 2.2M | -2.56M | -5.52M | -8.73M | -2.82M | 5.51M | 5.28M | 6.33M | 5.98M | -2.43M | -4.19M | -4.01M | -7.24M | -1.71M | -2.1M | -5.47M | -20.29M |
Other Non-Cash Items | -1.92M | 4.19M | 9.3M | 11.67M | 11.2M | 16.8M | 10.13M | 6.61M | 5.75M | -5M | -4.19M | -6.89M | -2.85M | 560K | 5.66M | 8.92M | 6.09M | 4.4M | 1.05M | 764K | 1.54M | 3.16M |
Deferred Income Tax | -3.31M | -1.54M | -3.2M | -10.7M | -10.32M | -10.48M | -8.86M | -452K | -286K | -177K | -292K | -87K | -134K | -14K | -44K | 297K | 233K | 307K | 58K | -333K | -258K | -331.24K |
Change in Working Capital | 13.06M | 13.25M | 4.44M | -2.42M | -7.71M | -9.39M | -3.15M | -5.86M | -8.83M | -2.88M | 5.64M | 7.22M | 8.12M | 8.11M | -676K | -732K | -894K | -1.89M | -2.65M | -6.46M | -8.18M | -26.26M |
Operating Cash Flow | -337.52M | -306.36M | -279.12M | -252.02M | -229.94M | -198.38M | -182.92M | -164M | -156.56M | -157.1M | -145.33M | -142.59M | -130.77M | -114.41M | -98.43M | -86.41M | -71.01M | -67.22M | -69.5M | -61.91M | -58.87M | -56.24M |
Capital Expenditures | -1.01M | -889K | -799K | -1.26M | -1.57M | -2.93M | -3.08M | -2.37M | -2.98M | -3.6M | -5.62M | -7.29M | -6.48M | -4.89M | -2.89M | -1.66M | -1.49M | -1.86M | -2.05M | -2.36M | -2.97M | -2.42M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -49.23M | -79.27M | -79.27M | -79.27M | -30.04M | n/a | -20.28M | -165.03M | -165.03M | -165.03M | -190.71M | -45.96M | -45.96M | -45.96M |
Purchase of Investments | -1.13B | -730.07M | -355.66M | -361.11M | -450.5M | -486.66M | -532.27M | -842.5M | -825.18M | -862.47M | -793.91M | -532.06M | -680.05M | -590.46M | -551.14M | -693.59M | -408.83M | -357.78M | -389.47M | -147.62M | -209.43M | -224.95M |
Sales Maturities Of Investments | 708.46M | 720.28M | 787.56M | 616.18M | 667.84M | 733.82M | 701.87M | 673.17M | 703.99M | 659.09M | 682.35M | 647.58M | 512.62M | 394.86M | 258.03M | 198.14M | 162.9M | 119.08M | 144.75M | 161.84M | 189.23M | 207.56M |
Other Investing Acitivies | -213.11M | -213.11M | -213.11M | n/a | n/a | n/a | n/a | n/a | 49.23M | 79.27M | 79.27M | 79.27M | 30.04M | n/a | 20.28M | 165.03M | 165.03M | 165.03M | 190.71M | 45.96M | 45.96M | 45.96M |
Investing Cash Flow | -637.29M | -223.79M | 218M | 253.8M | 215.77M | 244.23M | 166.53M | -171.7M | -124.17M | -206.99M | -117.17M | 108.22M | -173.91M | -200.49M | -296M | -497.1M | -247.43M | -240.55M | -246.77M | 11.86M | -23.17M | -19.81M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -470.1K | -16.97M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 837.3M | -247.43K | -247.43K | -8.68K | 24.8K | 47K | 47K | 35K | 35K | 35K | 35K | 6K | 705K | 705K | 705K | 714K | 43K | 154K | 260K | 290K | 262K | 151K |
Financial Cash Flow | 958.94M | 958.98M | 117.11M | 15.71M | 13.35M | 13.28M | 12.13M | 324.01M | 353.52M | 353.52M | 353.52M | 29.51M | 705K | 270.6M | 278.47M | 602.42M | 606.48M | 336.7M | 447.54M | 123.64M | 121.28M | 103.2M |
Net Cash Flow | -15.85M | 429.21M | 56.45M | 16.89M | -1.35M | 57.76M | -5.93M | -11.95M | 72.18M | -10.62M | 91.4M | -3.92M | -305.44M | -47.03M | -118.45M | 15.68M | 287.06M | 28.56M | 130.68M | 72.71M | 38.73M | 27.48M |
Free Cash Flow | -338.53M | -307.25M | -279.92M | -253.29M | -231.51M | -201.31M | -185.99M | -166.37M | -159.54M | -160.7M | -150.94M | -149.89M | -137.24M | -119.3M | -101.32M | -88.06M | -72.51M | -69.08M | -71.55M | -64.27M | -61.85M | -58.66M |
Adj. Free Cash Flow | -399.97M | -365.68M | -333.62M | -306.48M | -284M | -254.8M | -236.71M | -212.67M | -201.58M | -196.48M | -183.32M | -178.89M | -163.24M | -142.06M | -121.7M | -105.33M | -86.68M | -80.75M | -81.57M | -73.19M | -68.13M | -62.23M |
Maintenance CapEx | -1.01M | -889K | -756K | -1.22M | -1.53M | -2.89M | -3.08M | -2.37M | -2.98M | -3.6M | -5.62M | -7.29M | -6.48M | -4.89M | -2.68M | -1.44M | -1.06M | -1.42M | -1.83M | -1.77M | -1.98M | -1.07M |
Growth CapEx | n/a | n/a | -43K | -43K | -43K | -43K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -212K | -212K | -435K | -435K | -223K | -595.6K | -997.47K | -1.35M |
Owner Earnings | -338.53M | -307.25M | -279.87M | -253.24M | -231.47M | -201.27M | -185.99M | -166.37M | -159.54M | -160.7M | -150.94M | -149.89M | -137.24M | -119.3M | -101.11M | -87.85M | -72.07M | -68.65M | -71.33M | -63.67M | -60.85M | -57.3M |
Add to Watchlist
Select watchlists to add or remove XENE